SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-046373
Filing Date
2024-04-11
Accepted
2024-04-11 17:25:33
Documents
18
Period of Report
2024-04-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2411557d1_8k.htm   iXBRL 8-K 48336
2 EXHIBIT 2.1 tm2411557d1_ex2-1.htm EX-2.1 720161
3 EXHIBIT 10.1 tm2411557d1_ex10-1.htm EX-10.1 142571
4 EXHIBIT 10.2 tm2411557d1_ex10-2.htm EX-10.2 75798
5 EXHIBIT 99.1 tm2411557d1_ex99-1.htm EX-99.1 25603
9 GRAPHIC tm2411557d1_ex99-1img001.jpg GRAPHIC 12104
  Complete submission text file 0001104659-24-046373.txt   1433968

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20240411.xsd EX-101.SCH 3018
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20240411_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20240411_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2411557d1_8k_htm.xml XML 3816
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 24839363
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)